Metastatic malignant disease of unknown primary origin (CG104)
Fast, easy summary view of NICE guidance on 'metastatic malignant disease of unknown primary origin'
The advice in the NICE guideline covers:
- the treatment and care of adults with suspected or diagnosed cancer of unknown primary, including people who have been treated for cancer before.
In this guideline ‘cancer of unknown primary’ refers to a particular type of cancer, called carcinoma.
It does not specifically look at:
- children (under 18) with cancer of unknown primary
- adults with cancer, or likely to have cancer, that has spread (also called metastatic cancer) with a known site of primary origin
- adults with cancer that is not carcinoma (for example lymphoma, melanoma, sarcoma).
- CG104 Metastatic malignant disease of unknown primary origin: NICE guideline (web format)
- CG104 Metastatic malignant disease of unknown primary origin: evidence review
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: metastatic malignant disease of unknown primary origin
This page was last updated: 17 February 2014
- Web format
- Quick reference guide (PDF)
- NICE Guideline (PDF)
- Full Guideline (PDF)
- CG104 Canser nad yw ei darddiad sylfaenol yn hysbys: deall canllawiau NICE
Information for the public
Review decision date: TBC
Following consultation with stakeholders this guideline has now been placed on the static list.
Implementation tools and resources
- Audit support
- Baseline assessment tool
- Costing statement
- Slide set
- Metastatic malignant disease: online educational tool
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.